We are live on ! Find out more
S

Sanofi Portfolio holdings

AUM $336M
1-Year Est. Return 126.85%
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+126.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$25.5M
Cap. Flow
+$39.4M
Cap. Flow %
11.73%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AGMB
AgomAb Therapeutics NV
AGMB
+$39.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGTX icon
1
MeiraGTx Holdings
MGTX
$1.14B
$106M 31.44%
12,197,737
– –
INBX icon
2
Inhibrx
INBX
$1.21B
$77.8M 23.17%
1,157,926
– –
NVAX icon
3
Novavax
NVAX
$1.23B
$56M 16.67%
6,880,481
– –
ANAB icon
4
AnaptysBio
ANAB
$1.59B
$30.4M 9.04%
821,917
– –
AGMB
5
AgomAb Therapeutics NV
AGMB
$616M
$29.2M 8.69%
+2,783,096
New +$39.4M
MPLT
6
MapLight Therapeutics
MPLT
$449M
$18.5M 5.52%
912,041
– –
IMRX icon
7
Immuneering
IMRX
$282M
$14.3M 4.25%
2,708,559
– –
ELDN icon
8
Eledon Pharmaceuticals
ELDN
$276M
$2.51M 0.75%
814,980
– –
QTTB icon
9
Q32 Bio
QTTB
$452M
$1.57M 0.47%
244,083
– –

Similar funds

LFP
Leeward Financial Partners Bellevue, Washington $336M AUM 20.94% 1-Year Est. Return
HFS
Haverford Financial Services Radnor, Pennsylvania $336M AUM 20.46% 1-Year Est. Return
SG
Standard General New York $336M AUM 16.52% 1-Year Est. Return
TH
Team Hewins Redwood City, California $337M AUM 24.42% 1-Year Est. Return
SC
Schiavi & Co Wilmington, Delaware $337M AUM 16.69% 1-Year Est. Return
SIC
Shoker Investment Counsel Oxford, Ohio $337M AUM 24.9% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
PCM
Passive Capital Management Baltimore, Maryland $335M AUM 12.6% 1-Year Est. Return

Sanofi's Q1 2026 Portfolio in Review

As of Q1 2026, Sanofi held 9 positions worth $336M, up 8.2% from $310M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sanofi deployed $39.4M of net new capital in Q1 2026, opening 1 new position. Its largest new stake was AgomAb Therapeutics NV: 2,783,096 shares worth $29.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sanofi's largest Q1 2026 buy was AgomAb Therapeutics NV: 2,783,096 shares worth $29.2M.
  • Sanofi's ten largest holdings make up 100% of its $336M portfolio in Q1 2026.
  • Sanofi opened 1 new position and closed 0 in Q1 2026.
  • Sanofi's portfolio value rose 8.2% quarter-over-quarter to $336M.

Based on Sanofi's 13F filing for Q1 2026, filed 7 May 2026.